World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License and in accordance with our Terms of Use. Biotechnological health is going through what all other emerging scientific disciplines are experiencing: the challenge of defining its ethical limits. Research, costs and privacy issues raise concerns that third party payers, employers, suppliers and policy makers will face in the coming years.
